References
- Posner JB Neurologic complications of systemic cancer. Dis Mon 1978; 25: 1–60.
- Peltier AC, Russell JW. Recent advances in drug-induced neuropathies. Curr Opin Neurol. 2002; 15 (5): 633–638.
- Rudnicki SA, Dalmau J. Paraneoplastic syndromes of the peripheral nerves. Curr Opin Neurol. 2005; 18 (5): 598–603.
- Pritchard J, Hughes RA Gulllain-Barre syndrome. Lancet 2004; 26, 363: 2186–2188.
- Kuwabara S. Gulllain-Barre syndrome: epidemiology, pathophysiology and management. Drugs 2004; 64: 597–610.
- Maslovsky I, Volchek L, Blumental R, Ducach A, Lugassy G. Persistent paraneoplastic neurologic syndrome after successful therapy of Hodgkin's disease. Eur J Haematol 2001; 66: 63–65.
- Moudgil SS, Riggs JE. Fulminant peripheral neuropathy with severe quadriparesis associated with vincristine therapy. Ann Pharmacother 2000; 34: 1136–1138.
- Sarmiento MA, Neme D, Fornari MC, Bengio RM. Gulllain-Barre Sindrome following 2-chlorodeoxyadenosine treatment for Hairy Cell Leukemia. Leuk Lymphoma 2000; 39: 657–659.
- Re D, Schwenk A, Hegener P, Bamborschke S, Diehl V, Tesch H. Gulllain-Barre syndrome in a patient with non-Hodgkin's lymphoma. Ann Oncol 2000; 11 (2): 217–220.
- Christodoulou C, Anastasopoulos D, Visvikis A, et al. Gulllain-Barre syndrome in a patient with metastatic colon cancer receiving oxaliplatin-based chemotherapy. Anticancer Drugs 2004; 15 (10): 997–9.
- Hernandez-Boluda JC, Lis MJ, Goterris R et al. Gulllain-Barre syndrome associated with cytomegalovirus infec-tion after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2005; 7 (2): 93–96.
- Hartung HP, Kieseier BC, Kiefer R. Progress in Gulllain-Barre Syndrome. Curr Opin Neurol 2001; 14: 597–604.
- Antoine JC, Mosnier JF, Absi L, Conyers P, Honnorat J, Michel D. Carcinoma associated paraneoplastic peripheral neurophaties in patients with and without anti-onconeural anti-bodies. J Neurol Neurosurg Psychiatry 1999; 67: 7–14.